News und Analysen

Over the last month, the overall market has experienced significant selling amid increased uncertainty. The S&P 500 ETF Trust (NYSE: SPY) has traded almost 5.5% lower in that period, and wherever

The Health Care Select Sector SPDR Fund (NYSEARCA: XLV) is down 2.40% in the past three months, and down 4.67% year-to-date. 

With the current sector-wide downturn, it’s not surprising that

What started out to be a promising third quarter for U.S. stocks turned into a dud. On the backs of artificial intelligence (AI) excitement, the S&P 500 stormed out of the gates in July only to

If you had to guess the largest S&P company outside of big tech stocks or Berkshire Hathaway Inc. (NYSE: BRK.B), would you guess a healthcare stock? 

Health insurer UnitedHealth Group Inc. (NYSE:

The market advanced following the August PCE price index report, but investors and traders should not discount the news. The PCE index remains cool relative to the peaks of the inflation scare,

Med tech has been on the skids for no fault of its own. It’s not the industry's fault that price action was driven to a frothy bubble by COVID-inspired trading outlooks or that the market has

3M (NYSE: MMM) is an interesting speculation on high-yield dividend growth and value, and now is an excellent time to take a bite. The company is navigating a difficult time with aplomb, and the

For Walt Disney Co. (NYSE: DIS) shareholders, their brokerage statements haven’t exactly been the happiest place on earth. The stock has lagged the S&P 500 for the past 10 years, although it’s

The start of school means that autumn is just around the corner. As temperatures drop, certain seasonal factors come into play in the country and specific industries. The stock market is a

Real estate is one of the backbones of the American economy. As the latter begins to pivot into a cycle of uncertainty amid FED rate hikes and inflationary concerns, the housing market will surely

Glucose-monitor maker DexCom Inc. (NASDAQ: DXCM) was among the top three gainers within the healthcare sector on July 28, advancing 2.33% in the season after gapping higher at the open. 

The

It’s not unusual to see relatively new, unprofitable biotech stocks soaring on potential, particularly after promising clinical trial results.

But some stocks in the biotech category are rising for

Shares of health monitoring technology maker Masimo Corporation (NASDAQ: MASI) dropped 24% to $114.30 last week due to a second-quarter performance warning. They are at their lowest level since

The United States Economy is beginning to undergo a significant pivot, where specific industries will be rewarded with investment inflows over others. As the FED attempts to combat rampant inflation

Up more than 70% this year, Zillow Group, Inc. (NASDAQ:ZG) is one of the hottest technology stocks — and yet it's not exactly making a big splash.

In a market focused on artificial intelligence

Accolade Inc. (NASDAQ: ACCD) is an artificial intelligence (AI) powered healthcare platform that provides personalized healthcare guidance for employers and workers. The platform helps people

One simple signal that investors can use to decide if a stock is likely to move higher is to look at analyst sentiment. An analyst is a market professional employed by either funds that buy

Inspire Medical Systems (NYSE: INSP) is up nearly 15% since breaking out of cup-with-handle base on May 3. The base’s buy point was above $277.18, which you can see on the Inspire Medical Systems

Investors dream of getting into a promising stock early before it goes on a rocket ride. In hindsight, plenty of investors are kicking themselves for not seeing the potential of Apple Inc.

As shareholders of pet insurer Trupanion Inc. (NASDAQ: TRUP) learned last month, when you post a net loss that's twice what Wall Street expected, things get a little fuzzy.

The May 5

Patterson Companies, Inc. (NASDAQ: PDCO) is a dual-story that includes healthcare for humans and animals. The company operates in 2 segments, Dental and Animal Health, and both are growing. The

Agilent Technologies Inc. (NYSE: A) stock is underperforming the market, trading down 19% year-to-date. Agilent is a leading global provider of laboratory technologies and equipment.

It counts